ACHE and Alzheimer disease: This strategy may be particularly beneficial in conditions with compromised cholinergic function (e.g., in AD), in which PAMs alone may be ineffective due to scarce ACh levels or when the use of high doses of either agonists or acetylcholinesterase inhibitors may be limited due to adverse side effects.